Book a meeting
DO-BO

Can Innovative Contracting Turn High‑Cost Therapies into Sustainable Deals, Omar Ali?

In this thought‑provoking Market Access Podcast episode, host Stefan Walzer sits down with Omar Ali – Head of Payers at Vipora, former NICE advisor, and one of the sharpest minds in drug pricing and innovative contracting to unpack where drug pricing and reimbursement are really heading. 

They explore why cost‑effectiveness thresholds are making market access tougher than ever, how uncertainty around CAR‑T, gene therapies and orphan drugs fuels the “orphan bubble”, how innovative contracting and pay‑for‑performance can (sometimes) rescue multi‑million‑euro therapies and why the US is doing HTA at the end, not the beginning – with CMS negotiations, MFN and tariffs reshaping global pricing strategies. 

If you work in Market Access, pricing, Health Economics and Outcomes Research (HEOR) or policy, this conversation will resonate with the pressures you feel every day.

Related

Is Europe Still More Attractive Than the US, China, India or MENA for Medtech Investment, Bernard Bichsel?

By

Stefan Walzer

In the latest Market Access Podcast episode, host Stefan Walzer sits down with Bernard “Bernie” Bichsel – one of Europe’s most experienced voices in medtech regulation and former Head of the Medical Devices Division at Swissmedic – to unpack how regulation and market access truly fit together. They discuss why medical device regulation in Europe […]

From Necessary Tasks to New Insights: How Can AI Act as a Sparring Partner in Market Access, Helmut Butscher?

By

Stefan Walzer

In this episode, Stefan Walzer talks with experienced Market Access manager Helmut Butscher about concrete AI applications across the full Market Access value chain. They explore how AI accelerates systematic literature reviews, unlocks real‑world evidence from complex data sources, supports HTA dossier preparation, and enables smarter decisions on pricing, reimbursement and global launch sequencing. They […]

What Makes Australia’s HTA Approach to Equity and Health Productivity Unique, Zanfina Ademi?

By

Stefan Walzer

In this Market Access Podcast episode, Dr. Stefan Walzer sits down with Prof. Zanfania Ademi, a health economist at Monash University, to explore how Australia’s healthcare system is tackling key issues in market access and health technology assessment. Discover how Australia blends international approaches and new methods being developed by Zanfina and her team like […]